Strategic recommendations from the STARS project to foster academic drug development
Authors:
- Viktoriia StarokozhkoVSViktoriia Starokozhko
- Anne HeßAHAnne Heß
- Wiebke LöbkerWLWiebke Löbker
- Wolfgang BallensiefenWBWolfgang Ballensiefen
- Eleonora AgricolaEAEleonora Agricola
- Bettina ZiegeleBZBettina Ziegele
- Marko J. KallioMKMarko J. Kallio
- Laurence O’dWyerLOLaurence O’dWyer
- Yoana NuevoYNYoana Nuevo
- Peter G. M. MolPMPeter G. M. Mol
- Anna M. G. PasmooijAPAnna M. G. Pasmooij
- 8 February 2023
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 22 (4) , 251-252
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in EuropeClinical Pharmacology & Therapeutics, 2022
- Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gapDrug Discovery Today, 2021
- Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?ACS Pharmacology & Translational Science, 2020
- Putting translational science on to a global stageNature Reviews Drug Discovery, 2016
- Clinical development of gene- and cell-based therapies: overview of the European landscapeMolecular Therapy - Methods & Clinical Development, 2016